I'm inclined to agree, and I've seen others post t
Post# of 148152
Moderate, then mild will be the last groups offered LL. But given enough capacity and research, we may come to a different conclusion ultimately.
Perhaps we discover that one shot of LL in the mild stage prevents progression. It's far too early to tell how it plays out.